Hjem › Sigdcelleanemi › Georgia
Kliniske studier for Sigdcelleanemi i Georgia
25 studier for Sigdcelleanemi søker deltakere på steder i Georgia.
Byer i Georgia
Offisiell studietekst (engelsk)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Augusta University Georgia, Augusta
- WCG Sonar Clinical Research, Riverdale
RekruttererFase 3
Alder 12 til 100 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06439082A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- Emory University, Atlanta
- Augusta University, Augusta
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07187973A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Children's Healthcare Atlanta, Atlanta
RekruttererFase 3
Alder 2 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT06609226A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Children's Healthcare Atlanta, Atlanta
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06612268Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing
- Children's Healthcare of Atlanta, Atlanta
Rekrutterer
Alder 8 til 18 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07562451A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Winship Cancer Institute of Emory University, Atlanta
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT06481306A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Children's Center for Advanced Pediatrics, Atlanta
RekruttererFase 2/3
Alder 12 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Comprehensive Bleeding Disorders Center at Emory University and Children's Healthcare of Atlanta, Atlanta
- Emory/Children's Health Care of Atlanta, Atlanta
- Memorial Health University Medical Center, Savannah
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Arthur M. Blank Hospital-Children's Healthcare of Atlanta, Atlanta
RekruttererFase 2
Alder 12 og eldre · Alle kjønn · Oppdatert 14. aug. 2026 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Arthur M. Blank Hospital- Children's Healthcare of Atlanta, Atlanta
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. aug. 2026 · NCT07224360Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- Children's Healthcare fo Atlanta at Hughes Spalding, Atlanta
- Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
RekruttererFase 1/2
Alder 7 til 21 · Alle kjønn · Oppdatert 29. jul. 2026 · NCT02447874Cooperative Assessment of Late Effects for SCD Curative Therapies
- Emory University School of Medicine, Atlanta
RekruttererObservasjonsstudie
Alder 4 til 65 · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05153967Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
- Augusta University Georgia, Augusta
RekruttererFase 4
6 Months – 100 Years · Alle kjønn · Oppdatert 8. jun. 2026 · NCT04657822Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
- Children's Healthcare of Atlanta, Atlanta
RekruttererFase 1/2
Alder 12 til 45 · Alle kjønn · Oppdatert 4. jun. 2026 · NCT07252050Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Children's Healthcare of Atlanta (MRD-HCT), Atlanta
RekruttererObservasjonsstudie
Alder 3 til 20 · Alle kjønn · Oppdatert 4. jun. 2026 · NCT06941389Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
- Emory University, Atlanta
RekruttererFase 4
Alder 18 til 50 · Kvinner · Oppdatert 28. mai 2026 · NCT06665997A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
- Children's Healthcare of Atlanta, Atlanta
Rekrutterer
Alder 13 til 21 · Alle kjønn · Oppdatert 11. mai 2026 · NCT06290401Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
- Site # 8400006, Atlanta
- Site # 8400002, Atlanta
RekruttererFase 3
Alder 2 til 17 · Alle kjønn · Oppdatert 15. apr. 2026 · NCT07247188Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
- Grady Health System, Atlanta
RekruttererFase 4Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Kvinner · Oppdatert 18. feb. 2026 · NCT06979492A Long-term Follow-up Study in Patients Who Received BEAM-101
- Children's Healthcare of Atlanta - Aflac Cancer and Blood Disorders Center- Egleston, Atlanta
RekruttererObservasjonsstudie
Alder 14 til 37 · Alle kjønn · Oppdatert 28. jan. 2026 · NCT07373639Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease
- Children's Hospital of Atlanta: Eagelston, Atlanta
Rekrutterer
Alder 7 til 18 · Alle kjønn · Oppdatert 26. jan. 2026 · NCT07090668Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- Augusta University, Augusta
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 9. jan. 2026 · NCT01245179Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- Children's Healthcare of Atlanta, Atlanta
Rekrutterer
Alder 16 til 30 · Alle kjønn · Oppdatert 7. jan. 2026 · NCT06374238Integrative Training Program for Pediatric Sickle Cell Pain
- Children's Healthcare of Atlanta, Atlanta
- Arthur M. Blank Hospital | Children's Healthcare of Atlanta, Atlanta
Rekrutterer
Alder 12 til 18 · Alle kjønn · Oppdatert 14. nov. 2025 · NCT06691867Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- Augusta University, Augusta
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jun. 2025 · NCT06385886Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.